FDA Official Steps Down, Sued by Drugmaker The Wall Street Journal F.D.A. Drug Unit Chief Resigns, Citing a ‘Toxic’ Environment The New York Times FDA’s top drug regulator placed on leave, considering resigning, citing ‘toxic’ environment ABC News Director of FDA drug evaluation unit placed on leave, NYT reports Reuters FDA drug head Tidmarsh is put on leave, according to reports Endpoints News Source link
Read More »Tag Archives: drugmaker
Trump says Pfizer will cut drug prices for tariff relief, promises other drugmaker deals – Reuters
Trump says Pfizer will cut drug prices for tariff relief, promises other drugmaker deals Reuters Exclusive | White House Announces ‘TrumpRx’ Drug-Buying Site, and Pricing Deal With Pfizer The Wall Street Journal Pfizer agrees to offer discounted drugs through new federal website, Trump announces The Guardian Trump to announce deal with Pfizer to lower drug prices NBC News Trump Announces Pfizer Deal to Lower …
Read More »Trump blaming Tylenol for autism boosts lawsuits against the drugmaker : Shots
Last Monday, President Trump said Tylenol is linked to autism. He was joined by health officials — from left: Dr. Jay Bhattacharya, director of the National Institutes of Health, Dr. Marty Makary, Food and Drug Administration commissioner, Health and Human Services Secretary Robert F. Kennedy Jr., and Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services. Francis …
Read More »Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports – Reuters
Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports ReutersView Full Coverage on Google News Source link
Read More »Novo Nordisk Cuts Around 9,000 Jobs as Weight-Loss Drugmaker Faces Growing Competition
Key Takeaways Novo Nordisk said it is laying off about about 9,000 positions or 11.5% of its workforce in a “transformation” of the drugmaker’s business. The maker of Ozempic and Wegovy said the cuts are part of a plan to help the company grow its diabetes and weight-loss products. Novo Nordisk expects the job reductions will save about $1.25 billion …
Read More »Drugmaker Novo Nordisk freezes hiring for non-critical jobs – Reuters
Drugmaker Novo Nordisk freezes hiring for non-critical jobs Reuters Novo Nordisk’s new CEO is said to start hiring freeze to cut costs (NVO:NYSE) Seeking Alpha Novo Nordisk’s New CEO Starts Hiring Freeze in Cost-Cutting Push Bloomberg.com Pharmalittle: We’re reading about a Novo hiring freeze, coverage for GLP-1 drugs, and much more statnews.com Novo Nordisk’s Human Capital Shift: A Calculated Bet on R&D Efficiency and …
Read More »BioNTech Stock Rises as Drugmaker Beats Earnings Expectations. – Barron's
BioNTech Stock Rises as Drugmaker Beats Earnings Expectations. Barron’s BioNTech’s Q2 revenues double on higher COVID vaccine sales Yahoo Finance BioNTech Advances Oncology Strategy with New Collaborations and Financial Results for Q2 2025 Quiver Quantitative Biontech SE reports results for the quarter ended June 30 – Earnings Summary TradingView BioNTech SE Reports Strong Financial Results for Mid-2025 TipRanks Source link
Read More »Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning – The New York Times
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times Novo Nordisk Shares Plummet as Competition Weighs on Sales The Wall Street Journal Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance CNBC Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding NPR Wegovy maker Novo’s profit warning triggers $70 billion share rout Reuters Source …
Read More »Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again – Reuters
Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again Reuters Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance CNBC Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short Bloomberg.com Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO Yahoo Finance Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic MarketWatch Source link
Read More »